These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 23291385

  • 1. The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study.
    Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Lexberg AS, Rødevand E, Kalstad S, Mikkelsen K, Kvien TK.
    Ann Rheum Dis; 2014 Jan; 73(1):132-7. PubMed ID: 23291385
    [Abstract] [Full Text] [Related]

  • 2. Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden.
    Kristensen LE, Saxne T, Nilsson JA, Geborek P.
    Arthritis Res Ther; 2006 Jan; 8(6):R174. PubMed ID: 17121678
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.
    Greenwald MW, Shergy WJ, Kaine JL, Sweetser MT, Gilder K, Linnik MD.
    Arthritis Rheum; 2011 Mar; 63(3):622-32. PubMed ID: 21360491
    [Abstract] [Full Text] [Related]

  • 4. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS, Koldingsnes W, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.
    Arthritis Rheum; 2008 Feb 15; 59(2):234-40. PubMed ID: 18240258
    [Abstract] [Full Text] [Related]

  • 5. Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register.
    Lie E, van der Heijde D, Uhlig T, Mikkelsen K, Kalstad S, Kaufmann C, Rødevand E, Kvien TK.
    Ann Rheum Dis; 2011 Dec 15; 70(12):2103-10. PubMed ID: 21875874
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Symmons DP, Watson KD, Silman AJ, British Society for Rheumatology Biologics Register.
    Arthritis Rheum; 2006 Jun 15; 54(6):1786-94. PubMed ID: 16736520
    [Abstract] [Full Text] [Related]

  • 7. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
    Heiberg MS, Kaufmann C, Rødevand E, Mikkelsen K, Koldingsnes W, Mowinckel P, Kvien TK.
    Ann Rheum Dis; 2007 Aug 15; 66(8):1038-42. PubMed ID: 17213251
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register.
    Lie E, van der Heijde D, Uhlig T, Mikkelsen K, Rødevand E, Koldingsnes W, Kaufmann C, Kvien TK.
    Ann Rheum Dis; 2011 Jan 15; 70(1):157-63. PubMed ID: 21062852
    [Abstract] [Full Text] [Related]

  • 9. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.
    Int J Rheum Dis; 2012 Jun 15; 15(3):330-5. PubMed ID: 22709496
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E, van der Heijde D, Uhlig T, Heiberg MS, Koldingsnes W, Rødevand E, Kaufmann C, Mikkelsen K, Kvien TK.
    Ann Rheum Dis; 2010 Apr 15; 69(4):671-6. PubMed ID: 19740904
    [Abstract] [Full Text] [Related]

  • 11. Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    George MD, Baker JF, Ogdie A.
    J Rheumatol; 2020 Jun 01; 47(6):826-834. PubMed ID: 31474599
    [Abstract] [Full Text] [Related]

  • 12. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT.
    Arthritis Rheum; 2006 Jan 01; 54(1):26-37. PubMed ID: 16385520
    [Abstract] [Full Text] [Related]

  • 13. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC, Roseman C, Jönsson G, Truedsson L, Saxne T, Geborek P.
    Arthritis Rheum; 2011 Dec 01; 63(12):3723-32. PubMed ID: 21834061
    [Abstract] [Full Text] [Related]

  • 14. Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study.
    Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Kalstad S, Rødevand E, Mikkelsen K, Lexberg AS, Kvien TK.
    Ann Rheum Dis; 2013 Nov 01; 72(11):1840-4. PubMed ID: 23562987
    [Abstract] [Full Text] [Related]

  • 15. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
    Delaunay C, Farrenq V, Marini-Portugal A, Cohen JD, Chevalier X, Claudepierre P.
    J Rheumatol; 2005 Nov 01; 32(11):2183-5. PubMed ID: 16265699
    [Abstract] [Full Text] [Related]

  • 16. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN, Koukli EM, Katsalira A, Arida A, Petrou D, Komninou E, Fragiadaki K, Zacharioudaki A, Lasithiotakis I, Giavri E, Vaiopoulos G, Sfikakis PP.
    J Rheumatol; 2011 Nov 01; 38(11):2466-74. PubMed ID: 21885499
    [Abstract] [Full Text] [Related]

  • 17. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.
    Finzel S, Kraus S, Schmidt S, Hueber A, Rech J, Engelke K, Englbrecht M, Schett G.
    Ann Rheum Dis; 2013 Jul 01; 72(7):1176-81. PubMed ID: 22915620
    [Abstract] [Full Text] [Related]

  • 18. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
    Boyce EG, Halilovic J, Stan-Ugbene O.
    Clin Ther; 2010 Sep 01; 32(10):1681-703. PubMed ID: 21194591
    [Abstract] [Full Text] [Related]

  • 19. Joint tenderness and swelling in biologic-treated inflammatory arthritis patients - a tricky trade off?
    Harty LC, Ng CT, Fearon C, Murray CA, Fitzgerald O, Veale DJ.
    Int J Clin Pract; 2012 Feb 01; 66(2):128-31. PubMed ID: 22257038
    [Abstract] [Full Text] [Related]

  • 20. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
    Lie E, Kristensen LE, Forsblad-d'Elia H, Zverkova-Sandström T, Askling J, Jacobsson LT, ARTIS Study Group.
    Ann Rheum Dis; 2015 Jun 01; 74(6):970-8. PubMed ID: 25710471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.